The Pharmacy Times® Immunoglobulins Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.
August 14th 2025
Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.
FDA Approves Expanded Indication for Hyqvia to Treat Pediatric Primary Immunodeficiency
April 12th 2023During the 12-month trial period, Hyqvia was shown to be efficacious treating the occurrence of acute serious bacterial infections in children aged 2 through 16 years with primary immunodeficiency.
Read More
Clinical Overview: Lecanemab for the Treatment of Alzheimer Disease
January 30th 2023Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.
Read More
IVIG, Steroids for Multisystem Inflammatory Syndrome in Children Have Varying Outcomes
November 16th 2022Despite an apparent benefit of intravenous immunoglobulin (IVIG) on early discharge, the likelihood of needing second-line treatment was 3 times higher in patients who initiated treatment with IVIG alone.
Read More
Effective Treatment for Some Patients with Arndt-Gottron Syndrome Can Be Achieved With IVIG
September 1st 2022Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.
Read More